{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:39:20Z","timestamp":1779237560893,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/bjc.2013.225","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T20:02:41Z","timestamp":1367956961000},"page":"1931-1935","source":"Crossref","is-referenced-by-count":40,"title":["Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours"],"prefix":"10.1038","volume":"108","author":[{"given":"W H Y","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P P","family":"Soe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S L","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"key":"BFbjc2013225_CR1","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","volume":"28","author":"AS Artz","year":"2010","unstructured":"Artz AS, Somerfield MR, Feld JJ, Giusti AF, Kramer BS, Sabichi AL, Zon RT, Wong SL (2010) American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol 28: 3199\u20133202","journal-title":"J Clin Oncol"},{"key":"BFbjc2013225_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/hep.1840160104","volume":"16","author":"CK Chou","year":"1992","unstructured":"Chou CK, Wang LH, Lin HM, Chi CW (1992) Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology 16: 13\u201318","journal-title":"Hepatology"},{"key":"BFbjc2013225_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1478-3231.2004.0964.x","volume":"24","author":"MS Dai","year":"2004","unstructured":"Dai MS, Wu PF, Shyu RY, Lu JJ, Chao TY (2004) Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration. Liver Int 24: 540\u2013546","journal-title":"Liver Int"},{"key":"BFbjc2013225_CR4","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.2011.35.1635","volume":"29","author":"FL Day","year":"2011","unstructured":"Day FL, Karnon J, Rischin D (2011) Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors. J Clin Oncol 29: 3270\u20133277","journal-title":"J Clin Oncol"},{"key":"BFbjc2013225_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1200\/JCO.2008.17.1405","volume":"27","author":"PM Fidias","year":"2009","unstructured":"Fidias PM, Dakhil SR, Lyss AP, Loesch DM, Waterhouse DM, Bromund JL, Chen R, Hristova-Kazmierski M, Treat J, Obasaju CK, Marciniak M, Gill J, Schiller JH (2009) Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 27: 591\u2013598","journal-title":"J Clin Oncol"},{"key":"BFbjc2013225_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM (2004) Hepatitis B virus infection \u2013 natural history and clinical consequences. N Engl J Med 350: 1118\u20131129","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"BFbjc2013225_CR7","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1136\/gut.38.Suppl_2.S13","volume":"38","author":"R Guan","year":"1996","unstructured":"Guan R (1996) Hepatitis B virus infection in Singapore. Gut 38 (Suppl 2): S13\u2013S17","journal-title":"Gut"},{"key":"BFbjc2013225_CR8","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1002\/hep.22945","volume":"49","author":"JH Hoofnagle","year":"2009","unstructured":"Hoofnagle JH (2009) Reactivation of Hepatitis B. Hepatology 49: S156\u2013S165","journal-title":"Hepatology"},{"key":"BFbjc2013225_CR9","first-page":"3035","volume":"24","author":"CH Hsu","year":"2004","unstructured":"Hsu CH, Hsu HC, Chen HL, Gao M, Yeh PY, Chen PJ, Cheng AL (2004) Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. Anticancer Res 24: 3035\u20133040","journal-title":"Anticancer Res"},{"key":"BFbjc2013225_CR10","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","volume":"24","author":"SE Jones","year":"2006","unstructured":"Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja S, McIntyre KJ, Pippen JE, Bordelon JH, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Meyer WG, Asmar L (2006) Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 24: 5381\u20135387","journal-title":"J Clin Oncol"},{"key":"BFbjc2013225_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3904\/kjim.2007.22.4.237","volume":"22","author":"MK Kim","year":"2007","unstructured":"Kim MK, Ahn JH, Kim SB, Im YS, Lee SI, Ahn SH, Son BH, Gong G, Kim HH, Kim WK (2007) Hepatitis B reactivation during adjuvant anthracycline-based chemotherapy in patients with breast cancer: a single institution's experience. Korean J Intern Med 22: 237\u2013243","journal-title":"Korean J Intern Med"},{"key":"BFbjc2013225_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1440-1746.1998.tb00539.x","volume":"13","author":"YF Liaw","year":"1998","unstructured":"Liaw YF (1998) Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 13: 14\u201320","journal-title":"J Gastroenterol Hepatol"},{"key":"BFbjc2013225_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","volume":"100","author":"AS Lok","year":"1991","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100: 182\u2013188","journal-title":"Gastroenterology"},{"key":"BFbjc2013225_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45: 507\u2013539","journal-title":"Hepatology"},{"key":"BFbjc2013225_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","volume":"148","author":"R Loomba","year":"2008","unstructured":"Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G (2008) Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 148: 519\u2013528","journal-title":"Ann Intern Med"},{"key":"BFbjc2013225_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","volume":"22","author":"C Tournigand","year":"2004","unstructured":"Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229\u2013237","journal-title":"J Clin Oncol"},{"key":"BFbjc2013225_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","volume":"83","author":"R Tur-Kaspa","year":"1986","unstructured":"Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA (1986) Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 83: 1627\u20131631","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2013225_CR18","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1056\/NEJMoa043116","volume":"352","author":"C Twelves","year":"2005","unstructured":"Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kroning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schuller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352: 2696\u20132704","journal-title":"N Engl J Med"},{"key":"BFbjc2013225_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","volume":"68","author":"JR Wands","year":"1975","unstructured":"Wands JR, Chura CM, Roll FJ, Maddrey WC (1975) Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 68: 105\u2013112","journal-title":"Gastroenterology"},{"key":"BFbjc2013225_CR20","first-page":"1","volume":"57","author":"CM Weinbaum","year":"2008","unstructured":"Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57: 1\u201320","journal-title":"MMWR Recomm Rep"},{"key":"BFbjc2013225_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jmv.10430","volume":"70","author":"W Yeo","year":"2003","unstructured":"Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ (2003) Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J Med Virol 70: 553\u2013561","journal-title":"J Med Virol"},{"key":"BFbjc2013225_CR22","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/sj.bjc.6601699","volume":"90","author":"W Yeo","year":"2004","unstructured":"Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM, Lam KC, Johnson PJ (2004) Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer 90: 1306\u20131311","journal-title":"Br J Cancer"},{"key":"BFbjc2013225_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bjc.2011.4","volume":"104","author":"J Yun","year":"2011","unstructured":"Yun J, Kim KH, Kang ES, Gwak GY, Choi MS, Lee JE, Nam SJ, Yang JH, Park YH, Ahn JS, Im YH (2011) Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. Br J Cancer 104: 559\u2013563","journal-title":"Br J Cancer"},{"key":"BFbjc2013225_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1352-0504.2003.00467.x","volume":"11","author":"S Zhong","year":"2004","unstructured":"Zhong S, Yeo W, Schroder C, Chan PK, Wong WL, Ho WM, Mo F, Zee B, Johnson PJ (2004) High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy. J Viral Hepat 11: 55\u201359","journal-title":"J Viral Hepat"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:14:32Z","timestamp":1684415672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFbjc2013225"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.225","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}